Skip to main content
. 2020 Jun 8;58(1):538–544. doi: 10.1080/13880209.2020.1770808

Figure 5.

Figure 5.

Socheongryongtang down-regulated the expression of CXCL1, CCL-2 and CCR2. (A) Socheongryongtang statistically significantly inhibited the DNA level of CXCL1 and trended towards suppressing the levels of CCL-2 and CCR2. (B) Socheongryongtang significantly suppressed the CXCL1 expression with 150 mg/kg treatment to an extent similar to that by Spiriva treatment. Socheongryongtang down-regulated the expression of CCL2 (C) and CCR2 (D). Each bar represents the mean ± SD (N = 8). Arrow, positive cells. *p < 0.05 vs. control group; $p < 0.05 vs. LPS intranasal instillation group; #p < 0.05 vs. Spiriva treatment group. Magnification, ×200.